Ovid Therapeutics Inc

Ovid Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel treatments for rare neurological disorders. It aims to discover and advance therapies addressing significant unmet medical needs for patients globally, with operations primarily in the United States. Operating within the Healthcare sector, Ovid Therapeutics Inc. is an American company focused on pioneering innovative compounds for severe neurological disorders. Its research aims to improve lives through groundbreaking scientific approaches, including treatments for drug-resistant epilepsies and related conditions. Keep up to date on the latest share price changes by adding OVID stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.